Daniilopoulou I, Vlachou E, Lambrou GI, Ntikoudi A, Dokoutsidou E, Fasoi G, et al
Given the enhanced therapeutic efficacy of D-CuP, it is a potential substitute for M-CuP in wound repair, cosmetics, and other applications
Timeline and Next Steps February 21, 2025: The FDA officially removes semaglutide from the drug shortage list
If this is paired with the stomach upset sometimes caused by gabapentin, it can lead to decreased appetite or dehydration
Who Should Not Take GLP-1 Medication
The drugs are in such high demand that its spurred counterfeit products that look similar but wont work, or could even be dangerous, the panelists said